CAJ | 학술논문

目的对泌尿生殖道炎症患者进行支原体培养及耐药检测,为,临床合理用药提供参考.方法采用法国生物梅里埃公司提供的Mycoplasma IST2支原体培养、鉴定、药敏一体化试剂盒,对484例非淋菌性尿道(宫颈)炎(NGU)患者分泌物进行支原体培养及药敏试验.结果 484例NGU患者,支原体感染阳性数为192例(占39.67%),其中uu感染数为155例(占32.02%) Mh感染数为11例(占2.27%):Uu+Mh混合感染教为26例(占5.37%).对支原体敏感的前四位药物依次为强力霉素、交沙霉素、原始霉素、四环素.结论 NGU患者主要以Uu感染为主,强力霉素、交沙霉素、原始霉素、四环素可以作为本地区NGU患者治疗的首选药物.
목적 대비뇨생식도염증환자진행지원체배양급내약검측,위,림상합리용약제공삼고.방법 채용법국생물매리애공사제공적Mycoplasma IST2지원체배양、감정、약민일체화시제합,대484례비림균성뇨도(궁경)염(NGU)환자분비물진행지원체배양급약민시험.결과 484례NGU환자,지원체감염양성수위192례(점39.67%),기중uu감염수위155례(점32.02%) Mh감염수위11례(점2.27%):Uu+Mh혼합감염교위26례(점5.37%).대지원체민감적전사위약물의차위강력매소、교사매소、원시매소、사배소.결론 NGU환자주요이Uu감염위주,강력매소、교사매소、원시매소、사배소가이작위본지구NGU환자치료적수선약물.
Objective To culture the Mycoplasma and detect the antibiotic resis- tance of patients with genitourinary tract inflammation,providing reference for clinical rational use of drugs.Methods Using Mycoplasma IST2 kits made by France biologic Merian company for Mycoplasma culture and antibiotic susceptivity assay to detect the secretion of 484 NGU patients.Rusults Amony the 484 samples,192 cases had Mycoplasma(39.67%).The single infection of Ureaplasma urealyticum(Uu) was in 155 cases(32.02%) and of Mycoplasma hominis(Mh) in llcases(2.27%),respectively,Uu+ Mh were in 26 cases(5.37%)oThe susceptivity to Mycoplasma ranking the first four places is doxycycline,josamycin,pristinamycin,tetracycline.Conclusion the major pathogeny for NGU patients is Uu,doxycycline,josamycin,pristinamycin,tetracycline will be as the first choice for NGU patients in this area.